Not Signed In - FDA Extends Prophylaxis Indication For Tamiflu To Children Between 1 To 12 Years Of Age
Fri, 23 Dec 2005 03:00 PM EST
... Roche announced that the US Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) extending the prophylaxis (prevention) indication for Tamiflu (oseltamivir phosphate) to include children ages one through 12. The leading prescription antiviral medication for prevention and treatment of influenza, Tamiflu was previously approved for prophylaxis in adolescents (age 13 years and older) and adults... click link for more info. ...
Related Topics
- Oseltamivir
- Carbetapentane and Chlorpheniramine
- Chlorpheniramine and Carbetapentane
- Oseltamivir Oral Suspension
- Thalidomide
- Carbetapentane and Chlorpheniramine oral suspension
- Macular Degeneration
- Carbetapentane, Phenylephrine, and Pyrilamine
- Carbetapentane, Phenylephrine, and Pyrilamine oral suspension
- Alcohol Consumption
- Cyanocobalamin Tablets
- Cyanocobalamin Capsules
- Cetirizine and Pseudoephedrine
- Tacrolimus ointment
- Death And Dying
- Ammonium Lactate Topical
- Mammography
- Cyanocobalamin Injection
- Loratadine and Pseudoephedrine
- Acetaminophen Oral Suspension or Syrup
email this page
print this page
bookmark this page
feedback on this page
